Houston, TX, United States of America

Thomas P Thrash

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Aviara Pharmaceuticals, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas P Thrash. Retrieved from https://idiyas.com/inventor/thomas-p-thrash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas P Thrash: Innovator in Pharmaceutical Chemistry

Introduction

Thomas P Thrash is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on propionic acid derivatives.

Latest Patents

Thomas P Thrash holds a patent for "Propionic acid derivatives and methods of use thereof." This patent includes compounds and pharmaceutical compositions of formula I, where R, R, R, R, R, and R are described in detail. The patent also covers pharmaceutically acceptable salts or stereoisomers of these compounds. Additionally, methods are provided for inhibiting the binding of an integrin to treat various pathophysiological conditions.

Career Highlights

Currently, Thomas P Thrash is associated with Aviara Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including Ronald J Biediger and Michele A Benish. These collaborations have fostered a productive environment for innovation and discovery.

Conclusion

Thomas P Thrash exemplifies the spirit of innovation in pharmaceutical chemistry, with his patent work paving the way for advancements in treatment methodologies. His contributions are a testament to the importance of research and collaboration in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…